Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof
A targeting and carrier technology, applied in the direction of non-active ingredients of polymer compounds, gene therapy, drug combination, etc., can solve the problems of poor targeting and low transfection efficiency, and achieve strong targeting and efficient targeting modification , reduce the effect of non-specific side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0060] Synthesis and Characterization of Polypeptide TATp-Cys-LHRHp
[0061] Apply peptide synthesizer, adopt solid-phase peptide synthesis technology to carry out peptide synthesis, the result of mass spectrometry analysis shows that its molecular ion peak is 2657 (see figure 1 ), consistent with the expected molecular weight of the polypeptide, analyzed by HPLC, its purity is greater than 99% (see figure 2 )
Embodiment 2
[0063] Preparation of TATp-Cys-LHRHp gene-carrying nanoparticles
[0064] Dissolve the polypeptide carrier (TATp-Cys-LHRHp) and plasmid DNA in water to prepare an aqueous solution, and then place the two aqueous solutions in a water bath at 37°C for 10 minutes; N / P (is it a molar ratio?) ratio of 10:1 The two solutions were quickly mixed and vortexed for 50 seconds to obtain TATp-Cys-LHRHp gene-carrying nanoparticles. The average particle size of the nanoparticles is about 82nm, and the zeta potential is 26mV.
[0065] N / P can be selected from 2:1 to 20:1, and the shaking time is selected from 40 to 60 seconds. The obtained TATp-Cys-LHRHp gene-carrying nanoparticles have an average particle size of about 70-90 nm and a zeta potential of 20-40mY.
Embodiment 3
[0067] Cell transfection experiments of TATp-Cys-LHRHp gene-carrying nanoparticles
[0068] According to the preparation method of TATp-Cys-LHRHp gene-loaded nanoparticles in Example 2, TATp-Cys-LHRHp gene-loaded nanoparticles with an N / P ratio of 10:1 were prepared, and then the nanoparticles were transfected into human liver cancer cells BEL-7402 and For normal human liver cells LO2, the amount of transfected nanoparticles is 5 μg DNA / ml calculated by DNA. After 24 hours of transfection, the results of high-content live cell imaging show that the nanoparticles have strong targeting effect on liver cancer cells BEL-7402 , its transfection efficiency is high, but the normal liver cell LO2 transfection efficiency is very low.
PUM
| Property | Measurement | Unit |
|---|---|---|
| particle size | aaaaa | aaaaa |
| particle size | aaaaa | aaaaa |
| particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 